Hayden is an assistant editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2021, where she produces written and video content covering multiple disease states.
She has a BA in journalism & media studies from Rutgers University. You can connect with Hayden on LinkedIn.
Study Reveals Factors That Further Increase Colorectal Cancer Risk for Adults With T2D
November 14th 2023The strongest associations between diabetes and colorectal cancer risk were observed in participants with a recent diabetes diagnosis and those who had not undergone recent colonoscopy, underscoring the significance of cancer screening.
Read More
Dr Natasha Halasa Lists Diarrheal Illness Challenges, Successful Treatment Strategies
November 10th 2023Natasha Halasa, MD, MPH, Vanderbilt University Medical Center, discusses the most pressing diarrheal illness challenges and successful strategies physicians can use to reduce this burden in patients.
Read More
Dr Amitkumar Mehta: CAR T-Cell and Bispecific Therapy Are Complementary, Not Competitors
November 9th 2023Amitkumar Mehta, MD, MBA, University of Alabama at Birmingham, notes the long-term data and potential curative effects of chimeric antigen receptor (CAR) T-cell therapy, while expressing optimism about bispecific therapy with ongoing evolution and the chance of significant patient responses.
Read More
Dr Edward Arrowsmith: Trust and Compromise Are Essential in Building Oncology Clinical Care Pathways
November 9th 2023Edward "Ted" Arrowsmith, MD, MPH, medical director for pathways at OneOncology and managing partner at Tennessee Oncology, highlights the need for trust between payers and providers, as well as finding balance in building consistent clinical pathways while prioritizing specific practice needs.
Read More
How Can Oncology Clinical Pathways Contribute to Burnout? Dr Lucy Langer Explains
November 8th 2023There is a lot of noise in the health care system, and oncologists need to collaborate and decide on common shared goals, said Lucy Langer, MD, MSHS, national medical director of oncology and genomics at UnitedHealthcare.
Read More
Dr Samyukta Mullangi on Leveraging Technology Intelligently in Oncology Care
November 8th 2023Leveraging technology intelligently can make the patient-doctor interaction much more seamless and connected, said Samyukta Mullangi, MD, MBA, medical director of oncology at Thyme Care, medical oncologist at Tennessee Oncology.
Read More
Dr Mona Shahriari Talks Unique Challenges in Treating Psoriasis in Patients With Skin of Color
November 4th 2023Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology, discusses unique challenges dermatologists face when treating patients with skin of color, who may present differently from White patients.
Read More
Dr Lalan Wilfong: EOM, Clinical Pathways Among Key Topics at PCOC 2023
November 3rd 2023Patient-Centered Oncology Care® (PCOC) 2023 has a diverse group of people coming in to discuss oncology, including payment reform and the future of oncology care, said Lalan Wilfong, MD, The US Oncology Network.
Read More
Multidisciplinary Surgical Team Approach Improves OS in Ovarian Cancer
November 1st 2023After implementing a multidisciplinary surgical approach, researchers found that use of the new approach, residual disease, and age were all independent predictors of overall and progression-free survival for patients with ovarian cancer.
Read More
Triplet Maintenance Therapy Effective in Platinum-Sensitive Recurrent Ovarian Cancer
October 31st 2023Results from the OPEB-01/APGOT-OV4 trial highlight the potential benefits of using olaparib, pembrolizumab, and bevacizumab as a triplet maintenance therapy for patients who have responded to chemotherapy after experiencing platinum-sensitive recurrence in ovarian cancer.
Read More
Dr Mona Shahriari Discusses Treatment of Plaque Psoriasis in Patients With Skin of Color
October 26th 2023Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology, provides on overview of the treatment landscape in patients with skin of color with plaque psoriasis.
Read More
Dr April Armstrong: Clinician Education Needed to Overcome AD Treatment Barriers
October 26th 2023April Armstrong, MD, MPH, of University of California, Los Angeles, gave an overview of her Fall Clinical Dermatology session on treating atopic dermatitis (AD) in patients with diverse skin tones and weighed in on how to address related treatment barriers.
Read More
Sacubitril/Valsartan Reduces Natriuretic Peptide Levels, Improves QOL in Patients With HFpEF
October 26th 2023The improvement in quality of life (QOL) seen with use of sacubitril/valsartan for heart failure with preserved ejection fraction (HFpEF) could potentially result in more favorable clinical results.
Read More
GALACTIC Trial Reveals Less Successful RAAS Inhibitor Uptitration in Women Than Men
October 24th 2023Uptitration of renin-angiotensin-aldosterone system (RAAS) inhibitors was less successful in women than men with acute heart failure (AHF), especially in those with HF with reduced ejection fraction.
Read More
Dr April Armstrong Identifies Main AD Health Care Gaps
October 24th 2023April Armstrong, MD, MPH, of University of California, Los Angeles, explained that the main health care gap within the atopic dermatitis (AD) realm is that many clinicians are not comfortable prescribing systemic medications.
Read More
Darker Skin Means Different Presentations of Skin Diseases, Explains Dr James Song
October 23rd 2023Recognizing that skin diseases such as atopic dermatitis, psoriasis, and hidradenitis suppurativa present differently in skin of color can prevent delays in diagnosis and treatment, explained James Song, MD, director of clinical research and associate chief medical officer at Frontier Dermatology.
Read More
Dr James Q. Del Rosso Explores the Latest Advancements in Dermatology
October 22nd 2023There are many drugs that have been around for years and others with strong data awaiting FDA approval that are beneficial in treating conditions like atopic dermatitis and alopecia areata, said James Q. Del Rosso, DO.
Read More
Dr James Song Addresses Disparities in HS Presentation, Severity Among Diverse Patients
October 20th 2023Atopic dermatitis, psoriasis, and hidradenitis suppurativa (HS) can present differently in diverse patients, potentially leading to delayed diagnosis and therefore delayed treatment, explained James Song, MD, director of clinical research and associate chief medical officer at Frontier Dermatology.
Read More
Dr Raj Chovatiya Calls Ruxolitinib Cream a Game Changer for Nonsegmental Vitiligo
October 20th 2023The FDA approval of topical ruxolitinib 1.5% cream changed the game for vitiligo treatment in both adult and pediatric patients, said Raj Chovatiya, MD, PhD, assistant professor of dermatology at Northwestern University's Feinberg School of Medicine.
Read More